Home  |  Contact

UniProtKB/Swiss-Prot P00966: Variant p.Gly14Ser

Argininosuccinate synthase
Gene: ASS1
Variant information

Variant position:  14
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Glycine (G) to Serine (S) at position 14 (G14S, p.Gly14Ser).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from glycine (G) to small size and polar (S)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In CTLN1.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  14
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  412
The length of the canonical sequence.

Location on the sequence:   MSSKGSVVLAYSG  G LDTSCILVWLKEQGYDVIAY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAY

Mouse                         MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAY

Rat                           MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAY

Bovine                        MSGKGSVVLAYSGGLDTSCILVWLKEQGYDVIAY

Chicken                       AEPRDTVVLAYSGGLDTSCILVWLKEQGYTVIAF

Xenopus laevis                SQSKGTVVLAYSGGLDTSCILVWLKEQGFDVIAY

Xenopus tropicalis            SQSKGMVVLAYSGGLDTSCILVWLKEQGYDVIAY

Zebrafish                     -MSKGLVVLAYSGGLDTSCILVWLKEQGYDVIAY

Drosophila                    -MPKETVILAYSGGLDTSCVLKWLLDKQYEVICV

Baker's yeast                 -MSKGKVCLAYSGGLDTSVILAWLLDQGYEVVAF

Fission yeast                 PQEVKRCVLAYSGGLDTSCILAWLIEEGWEVICY

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 412 Argininosuccinate synthase
Nucleotide binding 10 – 18 ATP


Literature citations

Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia.
Kobayashi K.; Jackson M.J.; Tick D.B.; O'Brien W.E.; Beaudet A.L.;
J. Biol. Chem. 265:11361-11367(1990)
Cited for: INVOLVEMENT IN CTLN1; VARIANTS CTLN1 SER-14; HIS-157; ASN-180; TRP-304; SER-324; TRP-363 AND ARG-390;

Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1).
Haeberle J.; Pauli S.; Schmidt E.; Schulze-Eilfing B.; Berning C.; Koch H.G.;
Mol. Genet. Metab. 80:302-306(2003)
Cited for: VARIANTS CTLN1 SER-14; LEU-40; GLN-127; ARG-179; ASP-190; GLU-202; MET-263; MET-269; SER-324; GLY-345 AND VAL-362;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.